Company: OSRH
Filing Date: 2025-01-31
Form Type: 424B3
Source: 0001213900-25-008874
Chunk: 575

Company: OSR Holdings, Inc.
Filing Date: 2025-01-31
Form: 424B3
Chunk 575
---
Level 2)   |     |   | Significant  
 Other        
 Unobservable 
 Inputs       
 (Level 3)    |
|:----------------------------------|:----|:--|--------------:|:----|:--|--------------:|:----|:--|:------------|:----|:--|:-------------|
| Assets:                           |     |   |               |     |   |               |     |   |             |     |   |              |
| Investments held in Trust Account |     | $ |    20,886,019 |     | $ |    20,886,019 |     | $ | —           |     | $ | —            |

F-23

BELLEVUE LIFE SCIENCES ACQUISITION CORP. NOTES TO CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2024 (UNAUDITED) NOTE 8 — FAIR VALUE MEASUREMENTS (cont.) The following table presents information about the Company’s assets that are measured at fair value on December 31, 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

|                                   |     |   | December 31, 
         2023 |     |   | Quoted Prices 
     In Active 
       Markets 
     (Level 1) |     |   | Significant 
 Other       
 Observable  
 Inputs      
 (Level 2)   |     |   | Significant  
 Other        
 Unobservable 
 Inputs       
 (Level 3)    |
|:----------------------------------|:----|:--|-------------:|:----|:--|--------------:|:----|:--|:------------|:----|:--|:-------------|
| Assets:                           |     |   |              |     |   |               |     |   |             |     |   |              |
| Investments held in Trust Account |     | $ |   36,605,106 |     | $ |    36,605,106 |     | $ | —           |     | $ | —            |

There were no transfers between Levels1, 2 and 3 during the nine months ended September 30, 2024 and year ended December 31, 2023. NOTE 9 — SUBSEQUENT EVENTS The Company evaluated subsequent events to determine if events or transactions occurred after the condensed balance sheet date up to the date the unaudited condensed financial statements were issued. The Company